Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Centre Hospitalier de l’Université de Montréal · Western University · +16 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
437
total citations
- FWCI
- 63.16
- Percentile
- 100%
- References
- 81
Citations per year
Authors
37- BRBertrand RoutyCorresponding
Centre Hospitalier de l’Université de Montréal
- JLJohn Lenehan
Western University, Lawson Health Research Institute
- WHWilson H. Miller
Jewish General Hospital, McGill University
- RJRahima Jamal
Centre Hospitalier de l’Université de Montréal
- MMMeriem Messaoudene
Centre Hospitalier de l’Université de Montréal
Topics & keywords
Topics
Keywords
- Pembrolizumab
- Nivolumab
- Medicine
- Transplantation
- Adverse effect
- Microbiome
- Clinical endpoint
- Melanoma
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.